(Q47929697)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15029207%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Prognostic impact of p27KIP1 expression in cyclin D1 positive lymphoproliferative disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15029207%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15029207%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Vincent Levy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15029207%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Ugo V

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15029207%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Valensi F

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15029207%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Radford-Weiss I

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15029207%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Nataf J

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15029207%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Gribben JG

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15029207%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Troussard X

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15029207%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Ajchenbaum-Cymbalista F

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15029207%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 May 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15029207%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15029207%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15029207%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15029207%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

953-961

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15029207%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403337

25 December 2019

exact match

0 references

cites work

Mantle-cell lymphoma: a population-based clinical study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

Somatic hypermutation and V(H) gene usage in mantle cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

Multiple functions of p27(Kip1) and its alterations in tumor cells: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

Protein expression of cell cycle regulator, p27Kip1, correlates with histopathological grade of non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

Biology and management of mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

Morphologic diagnosis of leukaemic B-lymphoproliferative disorders and the role of cyclin D1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

New functional activities for the p21 family of CDK inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

Cyclin E-CDK2 is a regulator of p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

7 January 2021

Mantle cell lymphoma, in leukaemic phase with prominent splenomegaly. A report of eight cases with similar clinical presentation and aggressive outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

7 January 2021

Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lymphoproliferative disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

7 January 2021

The morphologic spectrum of non-Hodgkin's lymphomas with BCL1/cyclin D1 gene rearrangements

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

7 January 2021

Chronic lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

7 January 2021

Mantle cell lymphoma in leukemic phase: characterization of its broad cytologic spectrum with emphasis on the importance of distinction from other chronic lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

7 January 2021

Cancer prognostics: past, present and p27

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

7 January 2021

p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

7 January 2021

Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

7 January 2021

Expression arrays illuminate a way forward for mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

7 January 2021

Mechanism of Cdk2/Cyclin E inhibition by p27 and p27 phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

7 January 2021

Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation index

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403337

7 January 2021